337 related articles for article (PubMed ID: 37500887)
21. IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer's Disease.
Lau SF; Chen C; Fu WY; Qu JY; Cheung TH; Fu AKY; Ip NY
Cell Rep; 2020 Apr; 31(3):107530. PubMed ID: 32320664
[TBL] [Abstract][Full Text] [Related]
22. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
[TBL] [Abstract][Full Text] [Related]
23. Microglial amyloid beta clearance is driven by PIEZO1 channels.
Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
[TBL] [Abstract][Full Text] [Related]
24. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states.
Dräger NM; Sattler SM; Huang CT; Teter OM; Leng K; Hashemi SH; Hong J; Aviles G; Clelland CD; Zhan L; Udeochu JC; Kodama L; Singleton AB; Nalls MA; Ichida J; Ward ME; Faghri F; Gan L; Kampmann M
Nat Neurosci; 2022 Sep; 25(9):1149-1162. PubMed ID: 35953545
[TBL] [Abstract][Full Text] [Related]
25. A core transcriptional signature of human microglia: Derivation and utility in describing region-dependent alterations associated with Alzheimer's disease.
Patir A; Shih B; McColl BW; Freeman TC
Glia; 2019 Jul; 67(7):1240-1253. PubMed ID: 30758077
[TBL] [Abstract][Full Text] [Related]
26. Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia.
Bassil R; Shields K; Granger K; Zein I; Ng S; Chih B
Nat Commun; 2021 Sep; 12(1):5220. PubMed ID: 34471104
[TBL] [Abstract][Full Text] [Related]
27. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
28. BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.
Sudwarts A; Ramesha S; Gao T; Ponnusamy M; Wang S; Hansen M; Kozlova A; Bitarafan S; Kumar P; Beaulieu-Abdelahad D; Zhang X; Collier L; Szekeres C; Wood LB; Duan J; Thinakaran G; Rangaraju S
Mol Neurodegener; 2022 May; 17(1):33. PubMed ID: 35526014
[TBL] [Abstract][Full Text] [Related]
29. In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages.
Hall-Roberts H; Di Daniel E; James WS; Davis JB; Cowley SA
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645588
[TBL] [Abstract][Full Text] [Related]
30. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice.
Kiani Shabestari S; Morabito S; Danhash EP; McQuade A; Sanchez JR; Miyoshi E; Chadarevian JP; Claes C; Coburn MA; Hasselmann J; Hidalgo J; Tran KN; Martini AC; Chang Rothermich W; Pascual J; Head E; Hume DA; Pridans C; Davtyan H; Swarup V; Blurton-Jones M
Cell Rep; 2022 Jun; 39(11):110961. PubMed ID: 35705056
[TBL] [Abstract][Full Text] [Related]
31. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease.
Jin M; Xu R; Wang L; Alam MM; Ma Z; Zhu S; Martini AC; Jadali A; Bernabucci M; Xie P; Kwan KY; Pang ZP; Head E; Liu Y; Hart RP; Jiang P
Cell Stem Cell; 2022 Jul; 29(7):1135-1153.e8. PubMed ID: 35803230
[TBL] [Abstract][Full Text] [Related]
32. Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia.
Washer SJ; Perez-Alcantara M; Chen Y; Steer J; James WS; Trynka G; Bassett AR; Cowley SA
Sci Rep; 2022 Nov; 12(1):19454. PubMed ID: 36376339
[TBL] [Abstract][Full Text] [Related]
33. Cystatin F (
Daniels MJD; Lefevre L; Szymkowiak S; Drake A; McCulloch L; Tzioras M; Barrington J; Dando OR; He X; Mohammad M; Sasaguri H; Saito T; Saido TC; Spires-Jones TL; McColl BW
Elife; 2023 Dec; 12():. PubMed ID: 38085657
[TBL] [Abstract][Full Text] [Related]
34. Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia.
Stöberl N; Donaldson J; Binda CS; McAllister B; Hall-Roberts H; Jones L; Massey TH; Allen ND
Sci Rep; 2023 Nov; 13(1):20477. PubMed ID: 37993517
[TBL] [Abstract][Full Text] [Related]
35. Human microglial state dynamics in Alzheimer's disease progression.
Sun N; Victor MB; Park YP; Xiong X; Scannail AN; Leary N; Prosper S; Viswanathan S; Luna X; Boix CA; James BT; Tanigawa Y; Galani K; Mathys H; Jiang X; Ng AP; Bennett DA; Tsai LH; Kellis M
Cell; 2023 Sep; 186(20):4386-4403.e29. PubMed ID: 37774678
[TBL] [Abstract][Full Text] [Related]
36. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
[TBL] [Abstract][Full Text] [Related]
37. Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes.
Funes S; Bosco DA
J Vis Exp; 2022 Aug; (186):. PubMed ID: 36063018
[TBL] [Abstract][Full Text] [Related]
38. Cardiolipin released by microglia can act on neighboring glial cells to facilitate the uptake of amyloid-β (1-42).
Wenzel TJ; Murray TE; Noyovitz B; Narayana K; Gray TE; Le J; He J; Simtchouk S; Gibon J; Alcorn J; Mousseau DD; Zandberg WF; Klegeris A
Mol Cell Neurosci; 2023 Mar; 124():103804. PubMed ID: 36592800
[TBL] [Abstract][Full Text] [Related]
39. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.
Lee S; Varvel NH; Konerth ME; Xu G; Cardona AE; Ransohoff RM; Lamb BT
Am J Pathol; 2010 Nov; 177(5):2549-62. PubMed ID: 20864679
[TBL] [Abstract][Full Text] [Related]
40. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
